First believers
Guillaume Meulle, Managing Partner

Congrats Gleamer!

We’re excited to announce that Gleamer, the leading European developer of AI solutions for medical imaging, has successfully concluded a Series B funding round, raising €26.5 million! The startup, founded in 2017, has been in our portfolio since 2018. To date, the startup has raised a total of €35.5 million, including €7.5 million in Series A in 2020 and €1.5 million in 2018.

XAnge has been a long-term partner for Gleamer, since the 2018 Seed Round. We still remain their main shareholder and participated in this Series B round led by Supernova Invest, alongside other investors, including Heal Capital, Elaia, Bpi France, MACSF, UI Investissement, Crista Galli Ventures, and several European radiologists.

Founded in 2017 by Christian Allouche, Alexis Ducarouge, and Dr. Noreddine Regnard, Gleamer views AI as a pivotal solution to meet the increasing demand for medical imaging, driven by the challenges of an aging population, rising prevalence of chronic diseases, and healthcare accessibility issues.

A comprehensive suite of AI solutions

Since the previous funding round in 2020, Gleamer have developed a suite of AI solutions to assist radiologists and clinicians in their diagnostic processes, providing greater reliability and optimizing the time required for image interpretation and analysis. With this new investment, Gleamer aims to expand its portfolio of solutions, strengthen its teams in Europe and the United States, and accelerate its international development.

Gleamer already offers a comprehensive catalog of solutions for standard radiology, including “BoneView” for detecting bone trauma lesions, “ChestView” for pulmonary pathology detection, “BoneMeasurement” for automating osteoarticular measurements, and “BoneAge” for automating bone age estimation.

All four solutions have obtained CE MDR Class IIa marking in Europe. Furthermore, BoneView has also received FDA certification for use in adults and children over the age of 2, making it the first and only FDA-approved AI solution for fracture detection in both adults and children in the United States.

1 million medical examinations per month: that’s AI at scale

These solutions have also gained global recognition within the scientific community, through nine publications in major medical journals. Deployed by over 6,500 users across 650 sites in 24 countries, Gleamer’s solutions currently process over a million medical examinations per month!

Now, its goal is to keep enhancing diagnostic accuracy, improve patient care, and optimize the workflow of medical personnel. By expanding the portfolio to include CT scans and mammography, Gleamer’s solutions will cover 70% of radiologists’ routine needs in the near future.

The aim is not to replace the expertise of the medical personnel, but to “augment” clinicians in their day-to-day job, in order for them to be more efficient and respond to the increasing demand for medical imaging.

Looking for more content ?

Subscribe to our Newsletter & Follow us on Social Networks

Discover our newsletter